Avenue Therapeutics Inc (ATXI) Annual Balance Sheets

Annual · GAAP · USD millions
Access ATXI quarterly Balance Sheets →
This balance sheet overview for Avenue Therapeutics Inc spans from Dec 31 2021 to Dec 31 2025, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent2.86
Cash & Short-term Investments2.00
Other Receivables, Net, Current0.00
Prepaid Expense And Other Assets Current0.08
Total Current Assets2.93
Total Assets2.93
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.47
Derivative Liability, Current DE0.00
Other Liabilities, Current0.63
Total Current Liabilities1.10
Total Long-term Debt0.00
Accrued Licenses Acquired Current-
Total Liabilities1.10
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock107.32
Retained Earnings / Accumulated Deficit-105.49
Defined Benefit Plan and Other0.00
Other Equity0.04
Common Stockholder's Equity1.87
Non-controlling interests & other0.00
Total Stockholder's Equity1.83
Liabilities & Stockholder's Equity2.93
4 historic quarters locked

Sign in to unlock the full Avenue Therapeutics Inc balance sheet history.

About Avenue Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-010359

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License